Latest pharma news Archives - Page 5 of 10 - DelveInsight

Latest pharma news

Pharma News
Moderna’s COVID-19 vaccine; AcelRx buys TetraPhase; Breakthrough designation to Baricitinib

Moderna announces dozing of first patient with its mRNA1273 vaccineThe pharmaceutical company, Moderna, has been developing a vaccine for the treatment of COVID-19. The vaccine is an mRNA-1273...


Pharma News
JNJ-6372 nabs FDA nods, Solid tumors treatment, Kevzara for COVID-19

The U.S. FDA has granted Janssen Pharmaceutical’s drug JNJ-6372, a Breakthrough Therapy designation for the treatment of metastatic non-small cell lung cancer (NSCLC) The drug has been re...


pharma news
Ofev’s expanded use; Arkin Bio-Ventures II launch; USD 125 M for COVID-19 treatment

Boehringer Ingelheim’s Ofev (nintedanib) has received FDA recommendation for the treatment of chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotypeInterstitial Lung D...


Pharma News
CAR-T in killing tumors; Amunix raises $73M; Autism findings in protein-targeted treatment

Killing brain tumors with the help of CAR-TCAR-T cell therapy is a technique which involves modifying patients' T cells to aim proteins associated with cancer that have revolutionized some of ...


Pharma news
Gilead to buy Forty Seven; Akrevia Therapeutics unveils new identity; FDA approved pyrimethamine

Gilead Sciences has announced to purchase an Immuno-oncology company Forty Seven for USD 95.50 per share, totalling up to a deal value of USD 4.9 billion.By acquiring Forty Seven – named afte...


Pharma News
US approval to Lundbeck’s Vyepti for preventive migraine care; Esperion’s cholesterol-lowering dr...

Formerly known as eptinezumab, Lundbeck’s Vyepti has received the recommendation from the US FDA for preventing migraine in adults.Estimated to affect women twice as compared to men, around 1...


Pharma News
Incyte meets endpoint in second atopic dermatitis trial; NeoTX lands USD 45 M series C; Five Prim...

Incyte meets endpoint in the second pivotal atopic dermatitis clinical trialA second phase 3 trial of Incyte’s ruxolitinib cream in atopic dermatitis has hit its primary endpoint. The back-to-...


PHARMA NEWS
J&J collaborates with BARDA; Virus kills pancreatic cancer cells; ALX raises USD 105 million...

J&J collaborates with BARDA to accelerate coronavirus vaccine programJohnson & Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to ...


Pharma News
Good news for Kite’s KTE-X19, and Aquestive’s Libervant; and a commercialization deal between ReF...

FDA has accepted Biological License Application submitted by Kite for its CAR-T cell therapy- KTE-X19, for relapsed or refractory mantle cell lymphoma (MCL)The drug- KTE-X19, which is an inves...


Pharma News
Immune cells for age-related diseases; Regeneron’s antibody for 2019-nCoV; FDA nods for hy...

Activated immune cells responsible for improving age-related diseasesThe main culprits of the inflammatory responses associated with asthma are Interleukins IL-33 and IL-5. There has been res...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.